Tirzepatide Side Effects: What You Need to Know

Tirzepatide has become an increasingly important medication for weight management and type 2 diabetes. It works by activating both GIP and GLP-1 receptors, which can decrease appetite, slow gastric emptying, improve glucose regulation, and support significant weight loss.

Like any prescription medication, however, tirzepatide can cause side effects.

Most tirzepatide side effects are gastrointestinal, particularly nausea, diarrhea, constipation, vomiting, and abdominal discomfort. These symptoms are often most noticeable when treatment begins or when the dose is increased and frequently lessen over time.

Understanding which symptoms are expected—and which may require medical attention—can make tirzepatide treatment safer and more comfortable.

What Is Tirzepatide?

Tirzepatide is a once-weekly injectable medication that activates two hormone receptors involved in appetite and blood sugar regulation: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

It is the active ingredient in Mounjaro®, which is FDA-approved to improve glycemic control in patients with type 2 diabetes, and Zepbound®, which is FDA-approved for chronic weight management in qualifying adults and for moderate-to-severe obstructive sleep apnea in adults with obesity.

Because tirzepatide affects digestion and appetite, many of its most common side effects involve the gastrointestinal system.

What Are the Most Common Tirzepatide Side Effects?

The most commonly reported side effects of Zepbound include:

Nausea

Diarrhea

Vomiting

Constipation

Abdominal pain

Indigestion

Injection-site reactions

Fatigue

Hypersensitivity reactions

Belching

Hair loss

Gastroesophageal reflux or heartburn

The exact likelihood of experiencing a side effect depends on factors such as your dose, medical history, other medications, and individual response.

In clinical weight-management trials, gastrointestinal symptoms were particularly common. Nausea occurred in approximately 25% to 29% of patients receiving 5-15 mg of Zepbound, diarrhea in 19% to 23%, vomiting in 8% to 13%, and constipation in 11% to 17%.

Importantly, the majority of nausea, vomiting, and diarrhea episodes occurred during dose escalation and decreased over time.

1. Nausea

Nausea is one of the most common tirzepatide side effects.

Tirzepatide slows gastric emptying and can make you feel full sooner and for longer periods. While this is part of how the medication can help reduce food intake, it may also contribute to nausea—particularly when you first begin treatment or increase your dose.

If you're experiencing mild nausea, strategies that may help include:

Eating smaller meals

Stopping eating when you begin to feel full

Avoiding high-fat or greasy foods

Choosing bland foods such as toast, crackers, or rice

Staying adequately hydrated

These approaches are also recommended in Lilly's patient guidance for managing gastrointestinal side effects.

If nausea becomes severe, persistent, or prevents you from drinking enough fluids, contact your healthcare provider.

2. Diarrhea

Diarrhea is another relatively common tirzepatide side effect.

In Zepbound's weight-management trials, approximately 19% to 23% of patients experienced diarrhea depending on the dose studied.

For mild diarrhea, maintaining adequate fluid intake is particularly important.

Lilly recommends drinking plenty of fluids and suggests bland foods while symptoms are present.

Persistent diarrhea should not simply be ignored. Significant fluid loss can lead to dehydration and kidney problems, especially when diarrhea occurs along with nausea or vomiting.

3. Constipation

Some patients experience the opposite problem: constipation.

Slower movement of food through the digestive tract can contribute to constipation during tirzepatide treatment.

Maintaining adequate fluid intake, remaining physically active, and consuming appropriate dietary fiber may help. However, significant abdominal pain, persistent constipation, progressive abdominal swelling, or inability to pass stool or gas warrants medical evaluation rather than simply taking additional laxatives on your own.

4. Vomiting

Vomiting occurred in approximately 8% to 13% of patients receiving the Zepbound doses studied in weight-management trials.

An isolated episode may not necessarily be concerning, particularly around a dose increase.

Repeated or persistent vomiting is different.

Vomiting can cause dehydration and electrolyte abnormalities and has been associated with cases of acute kidney injury in patients using GLP-1-based medications. The FDA-approved prescribing information specifically warns about kidney injury related to volume depletion from gastrointestinal symptoms.

Contact your healthcare provider if you're unable to keep liquids down or vomiting continues.

5. Abdominal Pain, Indigestion, Bloating and Heartburn

Some patients experience abdominal discomfort, indigestion, increased belching, bloating, gas, or gastroesophageal reflux while taking tirzepatide.

In Zepbound weight-management trials, abdominal pain occurred in approximately 9% to 10% of patients and dyspepsia in approximately 9% to 10%.

Mild discomfort may improve as your body adjusts.

Severe or persistent abdominal pain should not automatically be assumed to be a normal tirzepatide side effect, however, because abdominal pain can also be a symptom of pancreatitis or gallbladder disease.

6. Fatigue

Some people report feeling tired while taking tirzepatide.

Fatigue occurred in approximately 5% to 7% of patients receiving Zepbound in pooled weight-management trials.

Fatigue may sometimes occur alongside decreased caloric intake, gastrointestinal symptoms, dehydration, or rapid weight loss.

If significant fatigue persists, your healthcare provider may want to evaluate your nutrition, hydration, medications, sleep, and other possible causes.

7. Hair Loss

Hair loss can occur during tirzepatide-assisted weight loss.

In pooled Zepbound weight-management trials, hair loss occurred in roughly 4% to 5% of treated patients and was associated with weight reduction. It was reported more often in women than men.

Rapid or substantial weight loss itself can sometimes trigger temporary hair shedding, so hair loss doesn't necessarily mean that tirzepatide is directly damaging the hair follicle.

Discuss significant or persistent hair loss with your healthcare provider, particularly if you're also restricting calories substantially.

Serious Tirzepatide Side Effects and Warnings

Most patients will never experience the serious complications below, but knowing the warning signs is important.

Pancreatitis

Acute pancreatitis has been reported in patients treated with tirzepatide and other GLP-1 receptor agonists.

Symptoms may include:

Severe or persistent abdominal pain

Pain that may radiate into the back

Nausea

Vomiting

If pancreatitis is suspected, the current FDA-approved labeling instructs patients to discontinue Zepbound and seek appropriate medical evaluation.

Severe, persistent abdominal pain should be evaluated promptly.

Gallbladder Problems

Gallstones and gallbladder inflammation can occur during treatment.

In pooled Zepbound weight-management trials, gallstones were reported in 1.1% of treated patients versus 1.0% receiving placebo, while cholecystitis occurred in 0.7% versus 0.2%, respectively. Gallbladder events were associated with weight reduction.

Symptoms that may indicate gallbladder disease include significant upper abdominal pain, fever, jaundice, or other concerning gastrointestinal symptoms.

Dehydration and Kidney Injury

Nausea, vomiting, and diarrhea can result in significant fluid loss.

Postmarketing cases of acute kidney injury—including some requiring hemodialysis—have been reported, with many occurring in patients who developed dehydration from gastrointestinal adverse effects.

Maintaining hydration is therefore particularly important if you're experiencing vomiting or diarrhea.

Serious Allergic Reactions

Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with tirzepatide.

Seek immediate medical attention for symptoms such as:

Difficulty breathing

Swelling of the face, lips, tongue, or throat

Difficulty swallowing

Severe rash

Fainting or significant dizziness

Low Blood Sugar

Tirzepatide lowers blood glucose.

The risk of clinically significant hypoglycemia is especially important for people who also take insulin or medications such as sulfonylureas. Dose adjustments to those medications may sometimes be required.

Symptoms of low blood sugar may include sweating, shaking, weakness, dizziness, confusion, hunger, or rapid heartbeat.

Patients with diabetes should discuss glucose monitoring and medication adjustments with their prescribing clinician.

What About the Thyroid Cancer Warning?

Tirzepatide carries an FDA boxed warning regarding thyroid C-cell tumors.

Tirzepatide caused thyroid C-cell tumors in rats. However, it remains unknown whether tirzepatide causes medullary thyroid carcinoma in humans.

Zepbound and Mounjaro are contraindicated in patients with:

A personal history of medullary thyroid carcinoma (MTC)

A family history of MTC

Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Patients should tell their clinician about a new neck mass, persistent hoarseness, difficulty swallowing, or difficulty breathing.

This distinction is important: the boxed warning does not mean that tirzepatide has been proven to cause thyroid cancer in humans. The FDA labeling specifically states that the human relevance of the animal findings is unknown.

Tirzepatide and Surgery or Anesthesia

This is an important issue that patients can easily overlook.

Tirzepatide delays gastric emptying. Rare postmarketing reports of pulmonary aspiration during procedures requiring general anesthesia or deep sedation have occurred in patients taking GLP-1 receptor agonists despite reported adherence to preoperative fasting instructions.

If you're taking tirzepatide and are scheduled for surgery, an endoscopy, colonoscopy, or another procedure involving anesthesia or deep sedation, tell the physician and anesthesia team that you're taking tirzepatide.

Your procedural team can determine the appropriate plan based on your individual circumstances.

Tirzepatide and Birth Control Pills

Another lesser-known consideration involves oral contraceptives.

Because tirzepatide delays gastric emptying, it can temporarily reduce the effectiveness of oral hormonal contraceptives.

The current Zepbound prescribing information advises patients using oral hormonal contraception to either switch to a non-oral contraceptive or add a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after every dose increase.

This is an important issue to discuss with your healthcare provider before beginning treatment.

How Long Do Tirzepatide Side Effects Last?

There is no single timeline that applies to everyone.

However, gastrointestinal side effects are often most noticeable when treatment is started or the dose is increased.

In clinical trials, most nausea, diarrhea, and vomiting episodes occurred during dose escalation and became less frequent over time.

This is one reason tirzepatide dosing is gradually increased rather than immediately starting at a high dose.

If side effects remain significant, your clinician may decide that increasing the dose isn't appropriate yet or may recommend another strategy.

You do not necessarily need to reach the maximum dose to benefit from treatment.

How to Reduce Tirzepatide Side Effects

Several simple strategies may make treatment easier to tolerate:

Eat smaller portions. Large meals can worsen nausea and uncomfortable fullness.

Stop eating when you feel full. Continuing to eat beyond fullness may aggravate gastrointestinal symptoms.

Avoid very fatty or greasy meals. These can worsen nausea for some patients.

Choose bland foods temporarily if nausea or diarrhea develops.

Drink enough fluids, particularly if you're experiencing diarrhea or vomiting.

Do not increase your dose faster than prescribed.

Tell your healthcare provider when symptoms persist instead of simply pushing through them.

Lilly provides similar dietary recommendations for patients experiencing nausea or diarrhea while taking tirzepatide.

When Should You Call Your Healthcare Provider?

Contact your healthcare provider if you develop persistent vomiting or diarrhea, significant dehydration, severe or persistent abdominal symptoms, worsening gastrointestinal symptoms, or side effects that interfere with eating or drinking.

Seek urgent medical attention for severe abdominal pain—particularly if it radiates to the back—or symptoms of a serious allergic reaction.

The goal isn't simply to tolerate the highest possible tirzepatide dose.

The goal is to find a treatment strategy that provides meaningful benefit while remaining safe and tolerable.

Frequently Asked Questions About Tirzepatide Side Effects

What is the most common side effect of tirzepatide?

Gastrointestinal symptoms are the most common. Nausea is among the most frequently reported side effects, followed by diarrhea, constipation, vomiting, and abdominal discomfort.

Do tirzepatide side effects get worse at higher doses?

Some adverse events occur more frequently at higher doses, although this varies by symptom and patient. Gastrointestinal symptoms are particularly common during dose escalation.

Does tirzepatide cause nausea forever?

Not necessarily. Clinical trial data show that nausea, vomiting, and diarrhea occurred most frequently during dose escalation and generally decreased over time.

Can tirzepatide cause constipation?

Yes. Constipation is a recognized side effect and occurred in approximately 11% to 17% of patients receiving Zepbound in pooled weight-management trials, depending on dose.

Can tirzepatide cause hair loss?

Hair loss has been reported and was associated with weight reduction in Zepbound clinical trials.

Is tirzepatide safe?

Tirzepatide has been extensively studied and has an established FDA-approved safety profile for its approved indications, but it is not appropriate for everyone and can cause both common and serious adverse effects. Individual risks should be reviewed with a qualified healthcare professional.

The Bottom Line

For most patients, the most noticeable tirzepatide side effects involve the digestive system.

Nausea, diarrhea, constipation, vomiting, indigestion, and abdominal discomfort are common, particularly when treatment begins or the dose increases. Fortunately, these symptoms often improve over time.

More serious complications—including pancreatitis, gallbladder disease, dehydration-related kidney injury, severe allergic reactions, and hypoglycemia in susceptible patients—are much less common but require appropriate recognition and medical attention.

Tirzepatide treatment shouldn't be a race to reach the highest dose.

Appropriate dosing, medical supervision, hydration, good nutrition, and communication with your healthcare provider can make treatment safer and more comfortable.

Considering Tirzepatide for Weight Management?

If you're interested in tirzepatide or are already taking it and experiencing side effects, professional medical guidance can help determine the appropriate treatment and dosing strategy for you.

Our medical team can review your health history, weight-management goals, medications, laboratory results, and response to treatment to determine whether tirzepatide may be appropriate for you.

Schedule a consultation today to learn more about medically supervised weight-management options.

Medical Disclaimer: This article is intended for general educational purposes and does not constitute individualized medical advice. Tirzepatide is a prescription medication and should be prescribed and monitored by an appropriately licensed healthcare professional.